STK33
| Official symbol: | STK33 |
| Full name: | serine/threonine kinase 33 |
| Location: | 11p15.4 |
| Also known as: | |
| Entrez ID: | 65975 |
| Ensembl ID: | ENSG00000130413 |
| Summary: | |
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
|
|
|
| |
|
|
|
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
| Gscore (Amp): | 0.00 | | Gscore (Del): | 0.00 |
|
|
|
| |
|
|
|
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
|
|
|
| |
|
|
|
| |
Overall
|
|
Tissue specific
|
| |
| Total fusion occurrence: | 2 |
|
|
| Fusions detected in 1 cancer type(s) |
|
| |
|
|
|
| |
Overall
|
|
Tissue specific
|
| |
RNAi: STRONGLY SELECTIVE
|
|
|
| |
|
|
|
| Functional class: | Kinase (protein kinase) |
| JensenLab PubMed score: | 17.67 (Percentile rank: 45.42%) |
| PubTator score: | 9.90 (Percentile rank: 39.92%) |
| Target development/druggability level: | TchemThese targets have activities in ChEMBL or DrugCentral that satisfy the activity thresholds detailed below. |
| Tractability (small molecule): | Discovery PrecedenceTargets with ligands; Targets with crystal structures with ligands |
| Tractability (antibody): | |
